Go back to MDS Pharma Services home page


 
 
Spacer
Skip Navigation Links
2006 MDS Pharma Services News Releases

Company

Doubles North American testing capacity
October 17, 2006 - MDS Pharma Services, a leading provider of innovative drug discovery and development solutions, announced today that it has established its first central lab in the United States. The new 15,000 square-foot facility, located in North Brunswick, New Jersey is now fully operational, expanding MDS Pharma Services capabilities in late stage pharmaceutical testing. It provides central lab support services for clinical trials.

New therapeutic focus capitalizes on expertise in biomarkers and management of global clinical trials involving diabetes, dyslipidemia, obesity and metabolic syndrome
July 19, 2006 - MDS Pharma Services, a leading provider of innovative drug discovery and development solutions, has launched a new therapeutic focus on metabolic disorders such as diabetes, dyslipidemia, obesity and metabolic syndrome - a cluster of conditions that damage the cardiovascular system.

Recognized by Thomson CenterWatch as a preferred provider of late phase clinical trial management service
June 15, 2006 - MDS Pharma Services, a leading provider of innovative drug discovery and development solutions, has been ranked the top contract research organization (CRO) in Europe in a survey of clinical trial investigators by Thomson CenterWatch, a leading provider of news, market intelligence and information services for the clinical research industry.

May 16, 2006 - General Electric and MDS Pharma Services announced today the availability of a new, automated in vitro micronucleus assay that incorporates GE Healthcare's IN Cell 1000 and IN Cell 3000 high content analysis platforms. This automated imaging assay enables an accurate, early assessment of the potential genotoxicity of novel drug candidates in early drug discovery and development.

April 27, 2006 - MDS Inc. (NYSE: MDZ; TSX: MDS), a leading provider of enabling products and services to the global life sciences markets, announced today that David Spaight has joined as President of MDS Pharma Services, effective immediately. Mr. Spaight will report directly to Stephen P. DeFalco, President and Chief Executive Officer of MDS Inc.

April 6, 2006 - MDS Pharma Services, a leading provider of innovative drug discovery and development solutions, has adopted DataLabs Clinical Electronic Data Capture (EDC) system for increased efficiency and flexibility in managing patient data from clinical trials in geographically diverse sites.

January 23, 2006 - MDS Pharma Services, a leading provider of innovative drug discovery and development solutions, has been selected as the preferred contract research organization (CRO) of the Multiple Myeloma Research Consortium (MMRC). MDS Pharma Services will manage multiple MMRC pre-clinical and clinical research efforts, including data management related to the MMRC's tissue collection program. The MMRC will also recommend MDS Pharma Services to industry partners as additional protocols are brought through the Consortium.

 

Archives

2008

2007

2006

2005

2004

2003

2002

2001


Spacer

© 2009 MDS Pharma Services     |     Corporate Governance     |     Legal     |     Privacy     |     Site Map